V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220006769 | 220002601 | 0 | null | Disease modification (D) | 2016-01-14 | 2016-01-14 | Nilotinib | N | N | 220030998 | NILOTINIB |
| 220006770 | 220002602 | 1.86 | 74.8 | Curative (C) | 2015-06-09 | 2015-06-09 | AML 19 TRIAL | Y | N | 220031000 | AML19 TRIAL |
| 220006771 | 220002602 | 1.8 | 69.5 | Curative (C) | 2014-01-06 | 2014-01-07 | AML 19 TRIAL | N | N | 220031000 | AML19 TRIAL |
| 220006772 | 220002603 | 1.85 | 68.7 | Curative (C) | 2013-04-19 | 2013-04-19 | AML 19 TRIAL | 01 | N | 220031002 | AML19 TRIAL |
| 220006773 | 220002603 | 1.62 | 75 | Curative (C) | 2017-10-29 | 2017-10-30 | FLAG + Idarubicin | N | N | 220031002 | FLAG + IDARUBICIN |
| 220006774 | 220002604 | 1.74 | null | null | null | 2015-07-03 | AML 19 TRIAL | 01 | Y | 220031004 | AML19 TRIAL |
| 220006775 | 220002605 | 0 | null | null | 2016-08-04 | 2016-08-06 | Nilotinib | N | N | 220031013 | NILOTINIB |
| 220006776 | 220002605 | 1.55 | 52.6 | Curative (C) | 2015-11-21 | 2015-11-23 | AML 19 TRIAL | Y | N | 220031013 | AML19 TRIAL |
| 220006777 | 220002605 | 1.54 | 58.4 | Curative (C) | 2013-12-20 | 2013-12-20 | AML 19 TRIAL | Y | N | 220031013 | AML19 TRIAL |
| 220006778 | 220002605 | 0 | 0 | Unknown (U) | null | 2017-01-06 | Nilotinib | N | N | 220031013 | NILOTINIB |
| 220006779 | 220002605 | null | 63.4 | Curative (C) | 2015-05-27 | 2015-05-27 | FLAG + Idarubicin | 01 | N | 220031013 | FLAG + IDARUBICIN |
| 220006780 | 220002606 | 1.78 | 0 | Curative (C) | 2017-05-18 | 2017-05-19 | Nilotinib | N | N | 220031027 | NILOTINIB |
| 220006781 | 220002607 | 1.55 | 73.6 | Curative (C) | 2016-05-26 | 2016-05-26 | AML 19 TRIAL | Y | null | 220031028 | AML19 TRIAL |
| 220006782 | 220002607 | null | 84.6 | Curative (C) | 2018-07-13 | 2018-07-13 | FLAG + Idarubicin | 02 | N | 220031028 | FLAG + IDARUBICIN |
| 220006783 | 220002608 | 1.57 | 70.2 | Curative (C) | 2017-10-27 | 2017-10-27 | null | N | N | 220031030 | NOT MATCHED |
| 220006784 | 220002608 | 1.62 | null | Curative (C) | 2016-02-17 | 2016-02-18 | FLAG + Idarubicin | N | null | 220031030 | FLAG + IDARUBICIN |
| 220006785 | 220002608 | 0 | 83.5 | null | 2015-03-14 | 2015-12-28 | Nilotinib | N | N | 220031030 | NILOTINIB |
| 220006786 | 220002608 | null | 0 | Palliative (P) | 2017-03-06 | 2017-03-06 | Nilotinib | 02 | N | 220031030 | NILOTINIB |
| 220006787 | 220002609 | null | 56.9 | null | 2014-03-30 | 2014-05-18 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220031043 | CISPLATIN + GEMCITABINE |
| 220006788 | 220002610 | 1.6 | 71.6 | Palliative (P) | 2014-10-30 | 2014-11-03 | CISPLATIN + GEMCITABINE | 2 | N | 220031044 | CISPLATIN + GEMCITABINE |
| 220006789 | 220011514 | 1.52 | null | Curative (C) | null | 2013-08-31 | AML 18 TRIAL | Y | N | 220031045 | AML18 TRIAL |
| 220006790 | 220002611 | 1.65 | 65 | Curative (C) | 2015-07-20 | 2015-07-26 | AML16 DA 3+10 | N | N | 220031046 | AML16 TRIAL |
| 220006791 | 220002611 | 1.59 | 111.5 | Palliative (P) | 2017-07-12 | 2017-08-22 | CISPLATIN + GEMCITABINE | N | N | 220031046 | CISPLATIN + GEMCITABINE |
| 220006792 | 220002611 | 1.8 | 61.4 | null | 2017-10-15 | 2017-11-10 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220031046 | CISPLATIN + GEMCITABINE |
| 220006793 | 220002611 | 1.58 | 59.7 | Palliative (P) | 2017-09-20 | 2017-10-11 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220031046 | CISPLATIN + GEMCITABINE |
| 220006794 | 220002612 | 1.66 | 85.9 | Disease modification (D) | null | 2014-09-17 | AML18 PILOT TRIAL | null | Y | 220031051 | PILOT TRIAL |
| 220006795 | 220002612 | 1.52 | 90.6 | Curative (C) | 2015-08-04 | 2015-08-04 | AML18 PILOT TRIAL | Y | N | 220031051 | PILOT TRIAL |
| 220006796 | 220002613 | 150.7 | 78 | Curative (C) | null | 2015-08-03 | AML 18 TRIAL | Y | N | 220031059 | AML18 TRIAL |
| 220006797 | 220002614 | 1.82 | 83 | Palliative (P) | 2015-03-02 | 2015-03-13 | CISPLATIN + GEMCITABINE | N | N | 220031064 | CISPLATIN + GEMCITABINE |
| 220006798 | 220002615 | 1.79 | 72.2 | Palliative (P) | null | 2017-09-01 | GEMCARBO | 02 | null | 220031065 | GEMCARBO |
| 220006799 | 220011517 | 1.62 | 61.8 | Palliative (P) | 2017-10-28 | 2017-11-09 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220031069 | CARBOPLATIN + PACLITAXEL |
| 220006800 | 220011517 | null | 87 | null | 2013-06-21 | 2013-07-05 | GemCarbo Days 1+8 | N | N | 220031069 | GEMCARBO |
| 220006801 | 220018862 | null | 68.2 | Palliative (P) | 2014-03-16 | 2014-03-17 | GemCarbo Days 1+8 | null | N | 220031074 | GEMCARBO |
| 220006802 | 220018862 | 1.62 | 84 | Neo-adjuvant (N) | 2013-08-23 | 2013-08-26 | CARBOPLATIN + PACLITAXEL | 02 | N | 220031074 | CARBOPLATIN + PACLITAXEL |
| 220006803 | 220002616 | 1.85 | 61.6 | Palliative (P) | 2015-08-04 | 2015-08-11 | Dasatinib | 2 | N | 220031078 | DASATINIB |
| 220006804 | 220002616 | 1.64 | 61.9 | null | 2017-06-16 | 2017-07-06 | GemCarbo Days 1+8 | N | N | 220031078 | GEMCARBO |
| 220006805 | 220002616 | null | 52.7 | Curative (C) | 2013-11-27 | 2013-12-02 | AML18 PILOT TRIAL | Y | N | 220031078 | PILOT TRIAL |
| 220006806 | 220002617 | 1.9 | 95 | Palliative (P) | 2013-06-22 | 2013-06-29 | GemCarbo Days 1+8 | N | N | 220031085 | GEMCARBO |
| 220006812 | 220002619 | null | 47 | Palliative (P) | 2015-01-07 | 2015-01-12 | Dasatinib | 2 | N | 220031099 | DASATINIB |
| 220006813 | 220011520 | 1.67 | 45.5 | Curative (C) | null | 2018-01-25 | AML 18 TRIAL | 01 | N | 220031102 | AML18 TRIAL |
| 220006817 | 220002621 | 1.56 | 72 | Palliative (P) | 2017-05-10 | 2017-06-13 | AML16 DA 3+10 | N | N | 220031114 | AML16 TRIAL |
| 220006818 | 220011522 | 1.6 | 58 | Curative (C) | 2015-03-10 | 2015-03-10 | AML18 PILOT TRIAL | 01 | N | 220031115 | PILOT TRIAL |
| 220006819 | 220011522 | 1.68 | null | Curative (C) | null | 2015-01-01 | AML 18 TRIAL | Y | N | 220031115 | AML18 TRIAL |
| 220006820 | 220011522 | 1.52 | null | Palliative (P) | 2015-09-15 | 2015-11-02 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220031115 | CISPLATIN + GEMCITABINE |
| 220006821 | 220011522 | 1.66 | 74.8 | Palliative (P) | 2017-06-21 | 2017-06-22 | GemCarbo Days 1+8 | 02 | N | 220031115 | GEMCARBO |
| 220006822 | 220002622 | null | 57.4 | Palliative (P) | 2015-08-06 | 2015-08-07 | CARBOPLATIN + PACLITAXEL | 3 | N | 220031125 | CARBOPLATIN + PACLITAXEL |
| 220006823 | 220002623 | 1.7 | 68.4 | Palliative (P) | 2015-09-13 | 2015-09-20 | Dasatinib | Y | N | 220031126 | DASATINIB |
| 220006824 | 220002624 | 1.71 | 57.1 | Palliative (P) | 2013-04-06 | 2013-05-08 | AML16 Low Dose Cytarabine | 02 | Y | 220031128 | AML16 TRIAL |
| 220006825 | 220002625 | 1.55 | 91.2 | Curative (C) | null | 2017-10-01 | AML 18 TRIAL | 01 | N | 220031130 | AML18 TRIAL |
| 220006826 | 220002626 | 1.6 | 89.3 | Palliative (P) | 2014-06-10 | 2014-07-08 | GemCarbo Days 1+8 | N | N | 220031131 | GEMCARBO |